Aranesp (TM) (darbepoetin alfa) administered once every other week treats anemia in patients with chronic kidney disease (CKD) not receiving renal replacement therapy.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 2002
has subject area
- 1103 Clinical Sciences (FoR)
- Urology & Nephrology (Science Metrix)